Ipsen S.A. (EPA:IPN)
112.00
+0.40 (0.36%)
Sep 29, 2025, 10:44 AM CET
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
Oncology | 2.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology Growth | 6.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neurosciences | 700.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neurosciences Growth | 6.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Diseases | 195.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Diseases Growth | 67.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Specialty Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Specialty Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Family Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Family Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
Europe | 1.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 6.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | 1.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | 12.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World | 896.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World Growth | 8.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eastern Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eastern Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Italy | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spain | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spain Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|